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ABSTRACT Large-scale models of signaling networks are beginning to be reconstructed and corresponding analysis
frameworks are being developed. Herein, a reconstruction of the JAK-STAT signaling system in the human B-cell is described
and a scalable framework for its network analysis is presented. This approach is called extreme signaling pathway analysis and
involves the description of network properties with systemically independent basis vectors called extreme pathways. From the
extreme signaling pathways, emergent systems properties of the JAK-STAT signaling network have been characterized,
including 1), a mathematical deﬁnition of network crosstalk; 2), an analysis of redundancy in signaling inputs and outputs; 3),
a study of reaction participation in the network; and 4), a delineation of 85 correlated reaction sets, or systemic signaling
modules. This study is the ﬁrst such analysis of an actual biological signaling system. Extreme signaling pathway analysis is
a topologically based approach and assumes a balanced use of the signaling network. As large-scale reconstructions of
signaling networks emerge, such scalable analyses will lead to a description of the fundamental systems properties of signal
transduction networks.
INTRODUCTION
Reconstructed biochemical reaction networks are founda-
tional to systems analysis in biology. Large-scale recon-
struction efforts have been successful for metabolic and
regulatory networks (Covert and Palsson, 2002; Forster et al.,
2003; Pramanik and Keasling, 1997; Reed and Palsson,
2003; Selkov et al., 1998); however, such efforts for large-
scale signaling processes are in their infancy (Bhalla and
Iyengar, 1999; Gilman et al., 2002). In silico analysis
frameworks for these reconstructed signaling networks will
need to be scalable and able to describe emergent proper-
ties that arise from the interconnectivity of the network
constituents. A recent approach has been developed to study
the topological properties of signaling networks (Papin and
Palsson, 2003), called extreme signaling pathway analysis
(ExSPA). This approach uses extreme pathway analysis
(Schilling et al., 2000) to characterize the properties of
signaling networks. ExSPA has been applied to a prototypic
signaling network to deﬁne and study properties of signaling
networks (Papin and Palsson, 2003). Systems properties
including input/output relationships and crosstalk were
mathematically deﬁned and described, and other emergent
properties were characterized, including correlated reaction
sets, pathway redundancy, and the participation of reactions
in network-based pathways.
Network reconstruction involves the integration of
multiple datasets to generate increasingly more accurate
models of biological processes (Herrgard et al., 2004; Price
et al., 2003; Reed and Palsson, 2003). The B-cell was
recently selected to apply large-scale approaches to elucidate
signaling networks (Gilman et al., 2002). The JAK-STAT
signaling network, particularly important for many immune
responses, is well-characterized in the human B-cell as well
as many other cell types (Aaronson and Horvath, 2002) (Fig.
1). Typically, the binding of a corresponding ligand to its
receptor induces dimerization of the receptor, which in turn
results in the activation of an associated kinase called a JAK.
The activated JAK protein then induces the phosphorylation
of a protein from the family of signal transducers and
activators of transcription (STATs). These STATs can form
homo- and heterodimers. Following the STAT dimerization
event, these proteins translocate into the nucleus and induce
expression of their target genes.
This study presents a large-scale reconstruction of the
JAK-STAT signaling network in the human B-cell. The
extreme signaling pathways were computed and an analysis
of the systems properties of the reconstructed JAK-STAT
network was then performed based on methods previously
developed (Papin and Palsson, 2003).
CONCEPTUAL FRAMEWORK AND METHODS
Stoichiometric formalism of signaling networks
The constraint-based modeling framework allows for the analysis of
biological networks by successively applying known constraints such as
mass balance, maximum capacity, and reaction irreversibility (Price et al.,
2003). After the application of these known constraints, the remaining
solution space can be characterized by calculating convex basis vectors that
provide a way to represent every possible ﬂux state of the network (Schilling
et al., 2000). These convex basis vectors are fundamental pathways of the
network, and studying them for genome-scale metabolic networks has
yielded biologically meaningful results (Papin et al., 2003). Signaling
network events are subject to mass balance and thermodynamic constraints.
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Consequently, in silico analysis methods within the constraint-based
framework developed for metabolic and regulatory networks can be applied
to signaling networks (Papin and Palsson, 2003).
A recently developed analysis method within the constraint-based
framework is extreme pathway analysis (Papin et al., 2003). With this
approach, the ﬁrst step is the creation of a stoichiometric matrix to represent
the primary chemical events that take place within a network. The rows of
this matrix correspond to network components (e.g., adenosine triphosphate
(ATP), interleukin 2 receptor, STAT6, etc.). The columns of this matrix
correspond to reactions (e.g., binding of interleukin 2 to its receptor,
homodimerization of STAT6, etc.). Each element of the matrix contains the
stoichiometric coefﬁcient of the given component in the associated reaction.
With a stoichiometric formalism, the underlying reactions of a network
model are explicitly deﬁned and forced to be chemically consistent. Since
this formalism requires explicit description of the reaction mechanisms, each
‘‘state’’ of a component must be accounted for in the network. For example,
a protein is differentially represented if it is phosphorylated than if it is not
phosphorylated. With such an explicit description of all the chemical
transformations in a network, the systemic effects of each component of
a network can be readily assessed.
Extreme signaling pathway analysis
Once the stoichiometric matrix has been deﬁned, topological analyses can be
used to make characterizations of network properties. Extreme pathways
(Schilling et al., 2000), elementary modes (Schuster et al., 2000), and
extreme currents (Clarke, 1988) are topological analysis methods based on
convex analysis (Rockafellar, 1970). Convex analysis allows for the study of
systems of equations with inequality constraints. Extreme pathways are
the minimal set of conically independent basis vectors that completely
characterize the fundamental functional states of a given reaction network
and that satisfy constraints on the directions of the network reactions (Papin
et al., 2003). Since extreme pathways are calculated directly from
a stoichiometric matrix, subject to constraints on reaction direction, they
can directly correspond to integrated functions of the signaling network as
a whole.
Extreme pathways have the following important characteristics: 1), they
are a unique and systemically independent set of basis vectors; 2), all routes
through the network can be described by nonnegative linear combinations
of the extreme pathways; and 3), time-invariant network properties are
characterized (Papin et al., 2003). Recently, this approach was extended to
describe signaling networks (Papin and Palsson, 2003), and herein the
application of extreme pathways to signaling networks is called ExSPA.
Time-scale separation in signaling networks
Extreme pathway analysis has been extensively used for the analysis of
metabolic networks (Papin et al., 2003). Since metabolic processes occur on
a scale of milliseconds to seconds and regulatory and growth processes
occur on a scale of minutes to hours, a quasi-steady-state assumption al-
lows for the interpretation of the extreme pathways as steady-state ﬂux
distributions in a metabolic network (Covert et al., 2001; Varma and
Palsson, 1994). The quasi-steady-state assumption has allowed for simu-
lations of dynamic concentration proﬁles for Escherichia coli metabo-
lism (Covert and Palsson, 2002; Varma and Palsson, 1994) using standard
temporal decomposition approaches. The timescales for events in signaling
networks like kinase and phosphatase activity (Goodman et al., 1998;
Lillemeier et al., 2001; Theurkauf, 1994; Vuong and Chabre, 1991), re-
ceptor internalization (Ferguson, 2001; Jullien et al., 2002), and regulatory
processes (McAdams and Arkin, 1998; Rivett, 1986; Zubay, 1973) are
approximately known (see Table 1). Consequently, extreme pathways of
signaling networks may be interpreted as steady-state ﬂux distributions. If
these transients are too rapid to be of importance they can be relaxed and
only the eventual transcription state is analyzed.
This approximation is also valid for the JAK-STAT signaling network.
Although inhibitory reactions have not been delineated in the reconstructed
network presented herein, their activity is an important consideration for the
TABLE 1 Approximation of the order of magnitudes for
signaling processes
Process
Order of
magnitude References
Signaling reactions ,10 s Goodman et al. (1998);
Vuoung et al. (1991);
Lillemeier et al. (2001);
Theurkauf et al. (1994)
Transcriptional
regulation
102 s Zubay (1973); Rivett (1986);
McAdams and Arkin (1998)
Receptor
internalization
102 s Jullien et al. (2002);
Ferguson et al. (2001)
FIGURE 1 Schematic of generalized reactions for
the JAK-STAT signaling network.
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application of extreme signaling pathways to its analysis and the steady-state
ﬂux approximation. The genes for the well-characterized suppressor of
cytokine signaling (SOCS) inhibitors of JAK-STAT signaling (Shuai and
Liu, 2003) are expressed as a result of STAT transcriptional activity. The
regulation of other inhibitors of JAK-STAT signaling (e.g., PIAS (protein
inhibitor of activated STAT) and SHP (Src homology phosphotase)
proteins) is less characterized (Shuai and Liu, 2003; Wormald and Hilton,
2004). Some data suggest that JAK-STAT signaling peaks at;30 min to 1 h
and can be sustained for multiple hours (Kalvakolanu, 2003), suggesting that
these mechanisms of inhibition operate over approximately an hour time
frame. Combined, these data suggest that the time frame for chemical
transformations involved in JAK-STAT signaling is an order of magnitude
slower than transcriptional events and the inhibition of the signaling. Since
the activated receptor-ligand complex can continue to phosphorylate STAT
proteins, there is a constant ‘‘source’’ of ﬂux in the network. The ‘‘sink’’ for
this ﬂux may be the transport of STAT proteins into the nucleus where they
lead to transcriptional events.
RESULTS
The JAK-STAT signaling network of the human B-cell was
reconstructed and ExSPA was applied to it. Emergent
properties can be studied using ExSPA, including 1), crosstalk;
2), pathway redundancy; 3), reaction participation; and
4), correlated reaction sets. These properties represent novel
structural characterizations of the JAK-STAT signaling
network in the human B-cell.
Reconstruction of JAK-STAT signaling network
in the human B-cell
A stoichiometric matrix was constructed for the chemical
reactions that characterize the known JAK-STAT signaling
system in the human B-cell. There are 15 receptors and 15
corresponding ligands accounted for in this reconstruction.
Each of these receptors has been identiﬁed in the human
B-cell. There are a total of 297 reactions (216 internal and
81 irreversible exchange) in the reconstructed JAK-STAT
signaling network (the corresponding reactions and associ-
ated references can be found in the supplementary material).
These reactions involve 15 ligand inputs and seven STAT
homo- and heterodimer outputs as listed in Table 2. This set
of reactions can be represented with a stoichiometric matrix
with reactions as columns and components as rows. The
metabolic and protein components of the signaling network
are also shown in Table 2. The full list of components
illustrates the interconnectivity of the signaling network with
other cellular processes, namely metabolism and protein
synthesis/degradation. For example, the cofactor conversion
of ATP to ADP drives the signaling system, and ATP
resynthesis is a primary function of metabolism. Addition-
ally, receptors will need to be synthesized. Such intercon-
nectivity between ‘‘disparate’’ cellular processes emphasizes
the need for integrated modeling approaches.
The actual process of network reconstruction can lead
to useful biological results. For example, it is important to
characterize the speciﬁcity of STAT substrates to the proper
JAK and the receptor. In this reconstruction, the phosphor-
ylation of the STATs is speciﬁc to a particular JAK-receptor
complex. If the STATs were speciﬁc solely to the receptor,
or solely to the JAK, the analysis would yield different
results. These characterizations illustrate the hypotheses that
can be generated (and subsequently tested) through the
process of network reconstruction.
Enumeration of extreme pathways
The extreme pathways were calculated for the JAK-STAT
signaling network (see Schilling et al., 2000 for a description
of the algorithm). There are 147 extreme pathways in this
network and they can be categorized in two groups (Fig. 2).
The ﬁrst category represents the classical signaling mecha-
nism involving one input and one output; there are 37 of the
TABLE 2 Inputs and outputs of the JAK-STAT signaling
network in the human B-cell
Inputs Outputs
ATP ADP
JAK1 Prolactin-JAK2 receptor-ligand complex
JAK2 Interleukin 2-JAK1 receptor-ligand complex
JAK3 Interleukin 2-JAK3 receptor-ligand complex
TYK2 Interleukin 3-JAK2 receptor-ligand complex
STAT1 Interleukin 5-JAK2 receptor-ligand complex
STAT2 Interleukin 6-JAK1 receptor-ligand complex
STAT3 Interleukin 7-JAK1 receptor-ligand complex
STAT4 Interleukin 7-JAK3 receptor-ligand complex
STAT5A Interleukin 9-JAK1 receptor-ligand complex
STAT6 Interleukin 9-JAK3 receptor-ligand complex
Prolactin Interleukin 10-JAK1 receptor-ligand complex
Interleukin 2 Interleukin 10-TYK2 receptor-ligand complex
Interleukin 3 Interleukin 10-TYK2-JAK1 receptor-ligand complex
Interleukin 4 Interleukin 11-JAK1 receptor-ligand complex
Interleukin 5 Interleukin 12-JAK2 receptor-ligand complex
Interleukin 6 Interleukin 12-TYK2 receptor-ligand complex
Interleukin 7 Interleukin 12-TYK2-JAK2 receptor-ligand complex
Interleukin 9 Interleukin 13 receptor-ligand complex
Interleukin 10 Interleukin 13-JAK1 receptor-ligand complex
Interleukin 11 Interleukin 13-JAK2 receptor-ligand complex
Interleukin 12 Interleukin 13-JAK2-JAK1 receptor-ligand complex
Interleukin 13 Interleukin 14-JAK1 receptor-ligand complex
Interleukin 15 Interleukin 14-JAK3 receptor-ligand complex
Interferon a/b Interleukin 14-JAK3-JAK1 receptor-ligand complex
Interferon g Interleukin 15-JAK1 receptor-ligand complex
Prolactin receptor Interleukin 15-JAK3 receptor-ligand complex
Interleukin 2 receptor Interferon a/b-JAK1 receptor-ligand complex
Interleukin 3 receptor Interferon a/b-TYK2 receptor-ligand complex
Interleukin 4 receptor Interferon a/b-TYK2-JAK1 receptor-ligand complex
Interleukin 5 receptor Interferon g-JAK1 receptor-ligand complex
Interleukin 6 receptor Interferon g-JAK2 receptor-ligand complex
Interleukin 7 receptor Interferon g-JAK2-JAK1 receptor-ligand complex
Interleukin 9 receptor STAT1 homodimer
Interleukin 10 receptor STAT3 homodimer
Interleukin 11 receptor STAT4 homodimer
Interleukin 12 receptor STAT5A homodimer
Interleukin 13 receptor STAT6 homodimer
Interleukin 15 receptor STAT1-STAT2 heterodimer
Interferon a/b receptor STAT1-STAT3 heterodimer
Interferon g receptor
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147 extreme pathways in this group. The second category
represents a concatenation of inputs to generate one output;
there are 110 of the 147 extreme pathways in this group.
Other categories of extreme signaling pathways, described
elsewhere (Papin and Palsson, 2003), are not found in this
set of extreme pathways, including signal pleiotropy (one
signaling input generates multiple signaling outputs) and
complex signaling events (multiple signaling inputs generate
multiple signaling outputs).
The complete set of extreme pathways of the JAK-STAT
signaling network are listed in the supplementary material.
Two representative pathways are shown in Fig. 3. Pathway
119 (the numbers represent the order in which the extreme
pathways are computed) is the formation of the activated
ligand-receptor complex. Pathway 1 demonstrates some of
the interconnectivity that exists in the JAK-STAT signal-
ing network herein (Fig. 3). This pathway describes the
activation of different STATs that then form heterodimers
(e.g., STAT1-STAT2 heterodimer is activated as a result of
the binding of ligands interferon g and interferon a/b to their
respective receptors). Although these pathways generally
describe ‘‘silos’’ that connect the activated ligand-receptor
complex to activated transcription factor, the reconstruc-
tion of the JAK-STAT signaling network is easily expanded
to include inhibitory reactions and additional signaling
moieties (e.g., mitogen-activated protein kinase (MAPK)
reactions) which will lead to further interconnectivity. These
pathways also depict the interconnectivity between signal-
ing, metabolic, and transcriptional regulatory networks.
Crosstalk in the JAK-STAT signaling network
‘‘Crosstalk’’ in signaling networks has been deﬁned as
network states that are a nonnegative linear combination of
extreme signaling pathways (Papin and Palsson, 2003) and
as such represents the interaction of systemically indepen-
dent routes in a reaction network. This system property can
be characterized by making pairwise comparisons of the
entire set of extreme signaling pathways. A pair of pathways
may have identical, overlapping, or disjoint input sets (e.g.,
a pathway with interleukin-2 and interleukin-4 as input
signals would overlap with a pathway that had interleukin-2
and interleukin-15 as input signals). Each pair of pathways
may likewise have identical, overlapping, or disjoint output
sets. Consequently, there are nine categories of crosstalk.
Since the extreme signaling pathways are a unique and
minimal set of basis vectors, this unambiguous deﬁnition and
categorization of crosstalk describes the interaction of fun-
damental functional states in a signaling network.
Various forms of crosstalk in the JAK-STAT signaling
network can be characterized with the ExSPA approach
(Papin and Palsson, 2003). For the JAK-STAT system, the
pairwise combinations of all extreme pathways (crosstalk)
have been grouped into one of the nine categories described
above. These categories and their respective biological
interpretations have been described (Papin and Palsson,
2003). For example, pairwise combinations of pathways
with disjoint inputs and disjoint outputs may correspond to
completely independent functions of a network even though
intracellular reaction may be shared. Pairwise combinations
of pathways with overlapping inputs and disjoint outputs
may correspond to economized uses of the network allowing
a small difference in a signaling input to generate a distinct
biological response.
The percentages of each type of crosstalk found in the
reconstructed JAK-STAT network are listed in Fig. 4. With
147 extreme pathways, there are 10,731 pairwise combina-
tions ((1472  147)/2). Approximately 99.8% of the pairs of
extreme signaling pathways have disjoint outputs and nearly
0.2% have identical outputs. There are no pairwise com-
binations of extreme pathways with overlapping outputs
since all the extreme pathways of the JAK-STAT network
have only one signaling output. Approximately 63.9%,
21.3%, and 14.8% of the pairwise combinations have
disjoint, overlapping, and identical input sets, respectively.
The high percentage of pairwise combinations with disjoint
sets of inputs and disjoint sets of outputs indicates a fairly
deterministic signaling network; there is very little ‘‘classi-
cal’’ crosstalk (i.e., identical signaling molecules used in
different signaling pathways (Schwartz and Baron, 1999))
as one input signal typically corresponds to one output
signal. As more signaling networks are comprehensively
reconstructed, the percentages of types of crosstalk in
different systems will be characterized and comparative
systems properties will be described.
Signaling redundancy
‘‘Pathway redundancy’’ is the multiplicity of routes through
a network by which identical inputs can generate identical
outputs. This emergent property has been characterized in
genome-scale metabolic networks (Papin et al., 2002a; Price
FIGURE 2 Signaling pathway types in the JAK-STAT network. Other
signaling types, not present in this network, include signal pleiotropy (one-
input, multiple-outputs) and cross talk (multiple inputs, multiple outputs).
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et al., 2002) and a prototypic signaling network (Papin and
Palsson, 2003). A signiﬁcant amount of redundancy in sig-
naling networks would suggest a lack of speciﬁcity for gener-
ating a particular output with multiple different signaling
inputs. A small degree of redundancy in a signaling network
would suggest a highly speciﬁc relationship between inputs
and outputs.
Signaling pathway redundancy has been characterized for
the JAK-STAT signaling network (Table 3). The systemic
signaling pathway redundancy calculation indicated that on
average there were four independent routes (extreme path-
ways) with identical signaling inputs and identical signaling
outputs (data not shown). The signaling pathway redundancy
can be further discriminated by the level of output and input
redundancy. Output redundancy is the number of extreme
pathways with identical outputs; a high output redundancy
corresponds to output signals that can be generated by way
of multiple systemically independent routes. Input redun-
dancy is the number of extreme pathways with identical
inputs; it is an indication of the inputs that have a high degree
of inﬂuence in the signaling network as each corresponding
extreme pathway corresponds to a unique function in the
network. Output redundancy and input redundancy are
related to the previous concepts of crosstalk between pairs of
extreme pathways with identical output and input signals,
respectively (Fig. 4, 3rd column and 3rd row). The output
redundancy and input redundancy values have been
calculated. The synthesis of the STAT1-STAT3 heterodimer
is the most redundant and the synthesis of the STAT3,
STAT4, and STAT6 homodimers is the least redundant.
High redundancy values are indicative of signal inputs and
outputs to which the signaling network is particularly robust
under network modiﬁcations.
Reaction participation in the JAK-STAT
signaling network
The ‘‘reaction participation’’ is the percentage of extreme
pathways in which a given reaction is used (Papin et al.,
2002b). The reaction participation values have been
FIGURE 3 Examples of extreme sig-
naling pathways of the JAK-STAT sig-
naling network. Pathway 119 (A)
corresponds to the binding of the in-
terferon g ligand to its receptor and the
subsequent formation of an activated
receptor-ligand complex. Pathway 1 (B)
corresponds to the activation of the
STAT1-STAT2 heterodimer by the in-
terferon g and interferon a/b bound
receptors. The names of the reactions
are in italics above the reaction arrows
(see supplementary material).
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calculated for the JAK-STAT signaling network (Fig. 5).
The reactions with participation values greater than 10% are
shown in the inset table. Plotting the data on a log-log scale
does not result in a strict linear relationship. However, there
is a decreasing relationship between the number of reac-
tions and their corresponding participation numbers, which
indicates the importance of a small number of reactions in
determining the phenotypic potential of the signaling
network.
For example, the exchange reactions of ATP and ADP
have 100% participation. These components are essential
for all the states of the signaling network since phosphate
transfer is the mechanism by which the signal propagates.
The exchange reactions (i.e., reactions that describe the
transfer of components across the system boundary) for
STAT1, STAT3, the STAT1-STAT3 heterodimer, and the
reaction SD7, which describes the formation of the STAT1-
STAT3 heterodimer, have the next highest participation
values. This result is in part a reﬂection of the calculations
described above regarding the high degree of output re-
dundancy for the STAT1-STAT3 heterodimer; the network
is structured such that there are multiple routes to synthesize
the STAT1-STAT3 heterodimer. There are 168 reactions that
participate in only one extreme pathway. Reactions with low
participation values correspond to reactions that have very
speciﬁc network functions. Manipulating reactions with low
participation values could allow for control of very speciﬁc
functions, potentially important for drug targeting.
The exchange reactions for STAT1, STAT3, STAT4,
STAT5A, and STAT6 homodimers participated in 5%, 4%,
4%, 7%, and 4% of the extreme signaling pathways,
respectively. These reaction participation values do not
correlate with the number of cytokines that activate the
respective STATs (i.e., the STATs activated by a greater
number of cytokines do not necessarily participate in
a greater number of reactions (see supplementary material)).
The reaction participation values for the exchange reactions
of heterodimers are signiﬁcantly higher than the exchange
reactions for homodimers. The exchange reactions for
STAT1-STAT3 and STAT1-STAT2 heterodimers partici-
pated in 33% and 16% of the extreme signaling pathways,
respectively. This result suggests that the combinatorial
expansion around a small number of already existing
components can allow for a signiﬁcant increase in the
number of distinct phenotypes. Similarly, the crosstalk
analysis indicated that 21% of the pairwise comparisons
consist of overlapping inputs and disjoint outputs. Together
these results suggest that signaling networks may be de-
signed to expand around an existing repertoire to generate ad-
ditional responses to environmental stimuli.
Correlated reaction sets
Reactions that always appear together in the set of extreme
pathways for a given network have been called ‘‘correlated
reaction sets’’ (Papin et al., 2002b); in other words, all the
possible states of the network that use these reactions use
them together. The correlated reaction sets for the JAK-
STAT signaling network in the human B-cell have been
calculated (Table 4). There are 85 correlated reaction sets.
An obvious correlated reaction set is the exchange reactions
for ATP and ADP; whenever ATP goes into the system,
ADP consequently has to come out (set 1). Additional
correlated reaction sets include the exchange reactions for
the ligand and receptor pairs (e.g., set 4). However, there are
exchange reactions for ligands and receptors that belong
to reaction sets with additional reactions (e.g., set 2). The
receptors associated with these ligands only bind to one
member of the JAK family in this network and consequently
FIGURE 4 Cross talk in the JAK-STAT signaling network of the human
B-cell. There are 10,731 pairwise combinations of the 147 extreme
pathways. Each value is the percentage of all pairwise combinations that
belong to the corresponding category.
TABLE 3 Signaling redundancy
STAT1
Homodimer
STAT1-STAT2
Heterodimer
STAT1-STAT3
Heterodimer
STAT3
Homodimer
STAT4
Homodimer
STAT5A
Homodimer
STAT6
Homodimer Number
0 0 1 0 0 0 0 48
0 1 0 0 0 0 0 24
0 0 0 0 0 1 0 11
1 0 0 0 0 0 0 8
0 0 0 0 0 0 1 6
0 0 0 0 1 0 0 6
0 0 0 1 0 0 0 6
The number of extreme signaling pathways with equivalent signal outputs and their respective signaling output are shown.
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the additional reactions are only present with the input of the
ligand and its corresponding receptor.
There are additional distinctions between the correlated
reaction sets that correspond to biological properties of
the JAK-STAT signaling network. One separation of the
reaction sets occurs with the ligands that result in the
activation of STAT proteins by way of different JAKs. For
example, reaction sets 5 and 6 each include reactions that
describe the phosphorylation of STAT6 by way of JAK1-
associated and JAK3-associated IL-4 dimerized receptors,
respectively.Thesupplementarymaterial contains the complete
list of correlated reaction sets and associated reaction and
compound abbreviations, as well as corresponding refer-
ences.
These correlated reaction sets provide hypotheses re-
garding regulatory control of the JAK-STAT signaling
network. It has been hypothesized that correlated reaction
sets in metabolic networks correspond to enzymes located on
the same operon or controlled by the same regulon (Papin
et al., 2002b). In signaling networks, correlated reaction sets
may correspond to proteins that are coordinately regulated. If
a deﬁned regulatory rule does not correspond to a correlated
reaction set, there may be additional functions of the
signaling components within the set that have not yet been
characterized. Thus, the correlated reaction set could be used
to generate hypotheses regarding regulatory rules and net-
work function of signaling components.
DISCUSSION
The JAK-STAT signaling network in the human B-cell has
been reconstructed. The extreme signaling pathways of this
network have been calculated and described. From the
extreme signaling pathways, emergent systems properties
have been characterized. These properties of the JAK-STAT
signaling network include 1), a deﬁnition of network crosstalk;
2), an analysis of redundancy in signaling inputs and
outputs; 3), a study of reaction participation in the network;
and 4), a delineation of correlated reaction sets. This
integrated, mathematical analysis of network properties has
been previously performed for a prototypic signaling
network; this study is the ﬁrst such analysis of an actual
biological signaling system, and novel properties have
been described.
Extreme signaling pathway analysis provides a concise
and unique description of network properties. Consequently,
extreme signaling pathways enable unambiguous descrip-
tions of systems properties. The extreme signaling pathways
are a conically independent basis set (Schilling et al., 2000)
FIGURE 5 Reaction participation in JAK-STAT
signaling network. The percentage of the extreme
signaling pathways in which the corresponding re-
action participates is indicated on the y axis. The inset
table only lists the reaction participation values greater
than 20% (abbreviations in supplementary material).
The inset plot is the reaction participation plotted on
a log-log scale.
TABLE 4 Representative correlated reaction sets
Set
number
Reaction
name Stoichiometry/Exchange
1 atp INPUT
adp OUTPUT
2 prl1 rPRL 1 j2/ rPRLj2
prl2 rPRLj2 1 PRL/ rlPRLj2
prl3 rlPRLj2 1 rPRLj2 1 2 atp/
2 adp 1 2PRLj2
PRL INPUT
rPRL INPUT
2PRLj2 OUTPUT
3 prl4 2PRLj2 1 stat5A/ 2PRLj2s5A
prl5 2PRLj2s5A 1 atp/ PRLj2s5Ap
prl6 PRLj2s5Ap/ 2PRLj2 1 stat5AP 1 adp
4 I4 INPUT
rI4 INPUT
5 il4i 2I4j1 1 stat6/ 2I4j1_s6
il4j 2I4j1_s6 1 atp/ I4j1s6p
il4k I4j1s6p/ 2I4j1 1 adp 1 stat6P
6 il4l 2I4j3 1 stat6/ 2I4j3_s6
il4m 2I4j3_s6 1 atp/ I4j3s6p
il4n I4j3s6p/ 2I4j3 1 adp 1 stat6P
Each set of reactions always appears together in a set of extreme pathways
for the JAK-STAT signaling network. The complete list of correlated
reaction sets, as well as the reaction and component abbreviations, are
provided in the supplementary material.
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and thus all physiological network steady states can be
decomposed into this set of pathways (Wiback et al., 2003).
Since they are derived from the application of mass balance
constraints, extreme signaling pathways represent actual
signaling states in a network, and thus described emergent
properties correspond to actual biological characteristics.
One such biological property is crosstalk, which has been
deﬁned as the nonnegative linear combination of extreme
signaling pathways (Papin and Palsson, 2003). Since the
JAK-STAT network studied herein is fairly deterministic,
the types of cross talk that occur are limited; nearly 64% of
pairwise combinations of extreme signaling pathways fall in
the category of disjoint inputs and disjoint outputs. Nonethe-
less, with;21% of the pairwise comparisons in the category
with overlapping inputs and disjoint outputs, there is more
complex control as the particular combination of inputs can
generate distinct signaling outputs. This analysis of crosstalk
is an explicit description of the important signaling network
property of interconnectivity.
In addition to the novel description of crosstalk for this
signaling network, the analyses of pathway redundancy,
reaction participation, and correlated reaction sets have
generated insights into network properties. For the JAK-
STAT network described herein, the formation of the
STAT1-STAT3 heterodimer has the highest degree of
pathway redundancy. This result suggests that the formation
of this transcription factor complex is more robust to
modiﬁcations in the network structure. Measures of pathway
redundancy indicate network functions that are both highly
specialized (low redundancy) and very generalized (high
redundancy), perhaps suggestive of system objectives.
Reaction participation calculations make a parallel analysis
of reaction function. The removal of reactions with low
participation in the extreme pathways would result in
speciﬁc control of a signaling network. The identiﬁcation
of correlated reaction sets provides hypotheses regarding the
coordination of regulatory control. These emergent proper-
ties have been discussed in detail for metabolic networks and
have been described for signaling networks (Papin and
Palsson, 2003).
Input/output relationships for the JAK-STAT signaling
network are relatively simple. Consequently, the emergent
properties calculated for the previous prototypic signaling
network (Papin and Palsson, 2003) have not all been
calculated for the JAK-STAT signaling network. Such
properties should arise in larger signaling networks once
they are reconstructed. For example, the JAK-STAT
signaling network can be expanded to include other
signaling components like STAT inhibitory proteins (e.g.,
SOCS protein (Yamada et al., 2003)), as well as MAPK
proteins and G-proteins which have both been implicated in
STAT activation (Jain et al., 1998; Pelletier et al., 2003).
Importantly, this modeling approach is scalable. Further
reﬁnements and modiﬁcations will not change the types of
results that have been presented here. Rather, discrepancies
between results in the different models will generate
hypotheses that can be tested and resolved.
There is much interest in describing and analyz-
ing ‘‘modules’’ and ‘‘motifs’’ of biochemical networks
(Hartwell et al., 1999; Milo et al., 2002; Rives and Galitski,
2003). Signaling modules often consist of arbitrary groups
of adjacent signaling reactions in the network that may oper-
ate together (e.g., (Bhalla and Iyengar, 1999; Hoffmann et al.,
2002)). These signaling modules may serve as important
conceptual tools for studying related signaling events. Their
deﬁnition is based on local network topology and a priori
deﬁnition of the investigator. In contrast, the extreme
signaling pathways are network-based characteristics and
the emergent properties calculated based on them carry no
investigator biases. Since extreme pathways describe
balanced uses of a biochemical network, the correlated
reaction sets described in this study are effectively ‘‘systemic
modules’’ because they are generated with consideration of
all network demands and the reactions in a set always
function together. Such systemic modules may contain
reactions that are not topologically adjacent in a visual
representation of the network (Papin et al., 2002b).
Extreme signaling pathway analysis details structural
properties of the mass-balanced representation of the JAK-
STAT signaling network. To date, the approach discussed
herein does not allow for dynamic analyses of concentration
proﬁles like recent analyses of signaling modules (e.g.,
Schoeberl et al., 2002). The JAK-STAT signaling model
does not yet include genetic feedback mechanisms that will
lead to a description of additional complex behavior
important for the physiology of the human B cell. Ac-
counting for genetic feedback and other dynamic processes
in a signaling network (e.g., an activated transcription factor
induces the synthesis of a protein that in turn inhibits the
corresponding signaling pathway) will require further work
on timescale separation of signaling, regulatory, and
metabolic processes. The JAK-STAT signaling network
herein is an example of the interconnectivity that exists
between signaling, metabolic, and transcriptional regulatory
networks (Fig. 6). This interconnectivity can be accounted
for with stoichiometric representations of biochemical
transformations and their subsequent analysis.
FIGURE 6 Signaling, metabolic, and transcriptional regulatory networks
are interconnected. For example, ATP and GTP, primary currencies of
signaling networks, are principal products of metabolic networks.
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Taken together, this study presents the ﬁrst constraint-
based analysis of an actual signaling network. The JAK-
STAT signaling system in the human B-cell is of central
importance in immune response and other vital cellular
processes. As the signaling network is further characterized
and reconstructed, the calculated extreme signaling path-
ways may allow for the description of novel biological
properties that will be important in medical and bio-
technological applications as they previously have for
metabolic networks (Carlson et al., 2002; Liao et al., 1996).
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